RobertDavidGuzyMDPhD
Pulmonology • Madison, WICritical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine
Assistant Professor at the University of Chicago
Dr. Guzy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-7203Fax+1 773-702-6500
Education & Training
Washington University in St. Louis School of MedicinePost-Doctoral Fellowship, 2012 - 2015- Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2014
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2008 - 2010
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2008
University of ChicagoPhD, 2000 - 2005- University of Puget SoundBS, Biology, 1995 - 1999
Certifications & Licensure
IL State Medical License 2015 - 2026
WI State Medical License 2022 - 2025
MO State Medical License 2011 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis.Yong Huang, Rob Guzy, Shwu-Fan Ma, Catherine A Bonham, Jonathan Jou
BMJ Open Respiratory Research. 2023-02-01 - 1 citationsSARS-CoV-2 infection reduces Krüppel-Like Factor 2 in human lung autopsyTzu-Han Lee, David Wu, Robert D. Guzy, Nathan Schoettler, Ayodeji Adegunsoye
Biorxiv. 2021-01-18 - 6 citationsFibroblast Growth Factor Inhibitors in Lung Fibrosis: Friends or Foes?Robert D. Guzy
American Journal of Respiratory Cell and Molecular Biology. 2020-09-01
Journal Articles
- Fibroblast Growth Factor 2 Decreases Bleomycin‐Induced Pulmonary Fibrosis and Inhibits Fibroblast Collagen Production and Myofibroblast DifferentiationDavid M Ornitz, Stacey L House, Robert D Guzy, The Journal of Pathology
Press Mentions
ATS Foundation Research Program Announces Unrestricted Grant Recipients for the 2019 CycleFebruary 13th, 2020
Grant Support
- Fellow To Faculty Transition AwardAmerican Heart Association2014–2019
- Outstanding Early Career Investigator AwardAmerican Thoracic Society2015–2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
